NUNZIUM

News That Matters

06/12/2022 ---- 12/12/2022

Leukaemia is cancer that affects the blood and bone marrow, where blood cells are produced. It is characterized by the uncontrolled growth of abnormal white blood cells, which can crowd out healthy blood cells and prevent them from functioning correctly, leading to symptoms such as fatigue, weakness, infections, and easy bruising or bleeding. Several different types of leukaemia are classified based on how quickly the disease progresses and the type of blood cells affected. Treatment often involves chemotherapy, radiation therapy, or bone marrow transplant and may include targeted drug therapies or immunotherapy. The prognosis varies depending on the type of leukaemia and the stage at which it is diagnosed. Still, many people with the disease can be successfully treated and go on to lead healthy, everyday lives. Alyssa, 13, was diagnosed with T-cell acute leukaemia in May last year. Chemotherapy and bone-marrow transplant were unable to rid it from her body. A team of doctors at Great Ormond Street, led by Prof Waseem Qasim, used a technology called base editing - invented only six years ago - on Alyssa with outstanding results. They used the most advanced methods to build her a new living drug based on a personalized T-cell capable of hunting down and killing Alyssa's cancerous T-cells. Base editing allows scientists to zoom into a specific part of the genetic code and alter the molecular structure of just one base, converting it into another and changing the genetic instructions. After a month of treatment, she was in remission and given a second transplant to rebuild her immune system. As she was left vulnerable to infection, she spent 16 weeks in the hospital and couldn't see her brother, who was still going to school, in case he brought germs. There were worries after the three-month check-up found signs of cancer again. But her two most recent investigations have been positive. Alyssa is the first patient to be treated with this technology. This outstanding result undoubtedly suggests that science has found a way to reduce leukaemia mortality. However, more statistics are needed to determine if the method can be called a "cure", which would be close to a miracle compared to the alternatives. Genetic manipulation, a high-speed moving area of science, confirms its true potential - which experts say goes across many incurable diseases.

READ MORE

On December 6, the 2022 midterm elections officially concluded after the vote in Georgia. The final result is 51/49 Senate seats for the Democrats and 222/213 in favour of the Republicans in the House. Nearly a month ago, after the vote in Nevada, it was already clear that the Democrats had control on at least 50% of the Senate seats, meaning a majority thanks to the power of casting vote of the Vice President (now Kamala Harris, a Democrat). The voice in Georgia, however, is significant as the Democrats won a crucial seat that allows them to keep the majority in the Senate even if a Republican vice president takes over in the next presidential elections. While victory in the Senate is undoubtedly important, the situation changed in the opposite direction in the House of Representatives. The Republicans had won control of the US House already on November 16, returning the party to power in Washington and giving conservatives leverage to blunt President Joe Biden's agenda and spur a flurry of investigations. Just one day after retaking a majority in the US House of Representatives, Republicans have said they will investigate the president's family as a "top priority". The lawmakers said the inquiry would focus on the overseas business dealings of the president's son, Hunter Biden. The 52-year-old is already under federal investigation but has not faced any charges. The younger Biden is not involved with the administration in any capacity. But top Republicans insist their inquiry will determine the extent of Joe Biden's alleged involvement in his son's business dealings, including during the elder Biden's time as vice president. This situation will complicate the ability to govern both parties during and after the ongoing presidential mandate. However, the results are more favourable than predicted for the Democrats, as Republicans hoped to entirely reset the agenda by capitalizing on economic challenges and Biden's lagging popularity. Despite a worse-than-predicted outcome, former President Donald Trump launched on November 15 his third campaign for the White House: "To make America great and glorious again, I am tonight announcing my candidacy for president of the United States," Trump said before an audience of several hundred supporters in a chandeliered ballroom at his Mar-a-Lago club, "America's comeback starts right now," he said, formally beginning the 2024 Republican primary. It is worth noting that Trump was the first president to be impeached twice, and his supporters violently stormed the Capitol during the transition of power on January 6, 2021. But the campaign of Donald Trump has to face more than "just" the proof of ballots. Recently, on December 7, a Manhattan jury found two Trump Organization companies guilty on multiple charges of criminal tax fraud and falsifying business records connected to a 15-year scheme to defraud tax authorities by failing to report and pay taxes on compensation for top executives. The Trump Organization could face a maximum of $1.61 million in fines when sentenced in mid-January. The guilty verdict comes as Trump is under scrutiny by federal and state prosecutors for his handling of classified documents, the effort to overturn the 2020 election results, and the accuracy of the Trump Organization's business records and financial statements. He is also facing a $250 million civil lawsuit from the New York attorney general alleging he and his adult children were involved in a decade-long fraud. The attorney general seeks to permanently bar them from serving as an officer or director of a company in New York state, among other penalties. Trump Org. attorneys said they plan to appeal.

READ MORE

Researchers have just caught bacteria sidestepping antibiotic treatment with a never-before-seen trick. Bacteria's talent for developing resistance against antibiotics is a rapidly growing health threat. This ability has ancient origins and allows drug-resistant bacterial infections like gonorrhoea to kill 1.3 million people globally yearly. Examples of strategies exploited by bacteria are: direct inactivation of the antibiotics, preventing drugs from accumulating in their system, and changing the antibiotic's targets, making them ineffective. Bacteria need their folates - a vitamin complex necessary for protein and DNA production - to develop and reproduce successfully. Some antibiotics block folate production to stop bacteria from growing and treat the infection. While investigating how a type of Streptococcus responds to antibiotics, Telethon Kids Institute microbiologist Kalindu Rodrigo and colleagues discovered a new mechanism for antibiotic evasion. Streptococcus commonly causes sore throats and skin infections but can also lead to systemic illnesses like scarlet fever and toxic shock syndrome. Scientists found a mechanism of resistance where, for the first time, the bacteria could take folates directly from its human host when blocked from producing their own. Streptococcus was acquiring folate, already processed, from outside its cells as these molecules are abundant in our bodies. The process completely bypasses the action of sulfamethoxazole, an antibiotic that inhibits folate synthesis within the bacteria, thus rendering the drug ineffective. The discovery's extent may impact preclinical research for antibiotics treatments. Indeed, bacteria that succumb to antibiotics in laboratory tests, where alternative folate sources are unavailable, may still thrive in their hosts' bodies. This study implies that most methods today may be inadequate for detecting resistance to some antibiotics.

READ MORE